ArticleMolecular diversity2025

Exploring chalcone-sulfonyl piperazine hybrids as anti-diabetes candidates: design, synthesis, biological evaluation, and molecular docking study.

Narges Hosseini Nasab et al.PubMed ↗Publisher ↗

No numbers read from the abstract.